Start New EnglishEspañol中文РусскийالعربيةTiếng ViệtFrançaisDeutsch한국어Tagalog Library Performance
BETA v.3.0

2025 ICD-10-CM code I69.818

Other symptoms and signs involving cognitive functions following other cerebrovascular disease.

Ensure the cognitive deficits are not better described by other more specific ICD-10 codes within the I69.81 category or elsewhere in the classification system. The specific cognitive symptoms should be clearly documented.This is a residual code, so only use after ruling out more specific codes.

Medical necessity for coding I69.818 hinges on demonstrating that the cognitive deficits are directly related to the cerebrovascular event and significantly impair the patient's functional abilities. This necessitates comprehensive documentation.

Neurologists, physiatrists, and other specialists involved in post-stroke rehabilitation and cognitive assessment may be responsible for diagnosing and managing conditions classified under this code.The clinical responsibility also involves documenting the specific cognitive symptoms and their impact on the patient’s daily functioning.

IMPORTANT:Consider using more specific codes from I69.81 (Cognitive deficits following other cerebrovascular disease) if applicable, such as I69.810 (Attention and concentration deficit), I69.811 (Memory deficit), I69.812 (Visuospatial deficit and spatial neglect), I69.813 (Psychomotor deficit), I69.814 (Frontal lobe and executive function deficit), or I69.815 (Cognitive social or emotional deficit).If the cognitive deficits are unspecified, use I69.819.

In simple words: This code describes other thinking or memory problems that happen after a stroke or other brain blood vessel problems, but are not specifically listed under other codes.It could mean trouble with remembering things, paying attention, or other brain function problems. The problem has to happen after the immediate period following the stroke or brain problem.

This code is used to classify other symptoms and signs affecting cognitive functions that occur after a cerebrovascular event (excluding traumatic injury).It encompasses various cognitive impairments not specifically categorized under other I69 codes, such as memory problems, attention deficits, or executive dysfunction, following a stroke or other cerebrovascular disease.The diagnosis must be established after the acute phase of the cerebrovascular event.

Example 1: A 65-year-old patient presents with persistent difficulties with executive function (planning, organization, and problem-solving) three months after a stroke. These deficits are not fully explained by other neurological impairments, such as hemiparesis.I69.818 would be appropriate., A 72-year-old patient experiences unexplained memory loss and difficulty with attention six months post-cerebral infarction.Neuropsychological testing reveals these are not solely attributable to depression or other comorbidities. I69.818 would be applicable., An 80-year-old patient has persistent difficulties with visuospatial processing and spatial neglect following a stroke. These cognitive deficits significantly impact daily activities (dressing, mobility).Neuroimaging rules out other causes. I69.818 would be considered.

Detailed neurological examination, neuropsychological testing results, imaging studies (MRI, CT), history of the cerebrovascular event, and documentation of cognitive symptoms with their impact on daily life.Detailed documentation is crucial,as this code is for other unspecified cognitive deficits that don’t fit into more specific codes.

** This code should only be used when no other more specific code is available to describe the cognitive deficits.The documentation should explicitly state that other possible causes have been ruled out.

** Only Enterprise users with EHR integration can access case-specific answers. Click here to request access.

Discover what matters.

iFrame™ AI's knowledge is aligned with and limited to the materials uploaded by users and should not be interpreted as medical, legal, or any other form of advice by iFrame™.